Steven J Mento - Net Worth and Insider Trading

Steven J Mento Net Worth

The estimated net worth of Steven J Mento is at least $238,848 dollars as of 2024-04-26. Steven J Mento is the President, CEO & Director of Conatus Pharmaceuticals Inc and owns about 385,669 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $215,975. Steven J Mento is also the Director of Sangamo Therapeutics Inc and owns about 44,046 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $22,873. Details can be seen in Steven J Mento's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven J Mento has not made any transactions after 2018-04-02 and currently still holds the listed stock(s).

Transaction Summary of Steven J Mento

To

Steven J Mento Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven J Mento owns 3 companies in total, including Histogen Inc (HSTO) , Sangamo Therapeutics Inc (SGMO) , and Dermata Therapeutics Inc (DRMA) .

Click here to see the complete history of Steven J Mento’s form 4 insider trades.

Insider Ownership Summary of Steven J Mento

Ticker Comapny Transaction Date Type of Owner
HSTO Histogen Inc 2020-05-22 director
SGMO Sangamo Therapeutics Inc 2018-04-02 director
DRMA Dermata Therapeutics Inc 2021-08-12 director

Steven J Mento Latest Holdings Summary

Steven J Mento currently owns a total of 2 stocks. Among these stocks, Steven J Mento owns 385,669 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $215,975 and a weighting of 90.42%. Steven J Mento also owns 44,046 shares of Sangamo Therapeutics Inc (SGMO) as of April 2, 2018, with a value of $22,873 and a weighting of 9.58%.

Latest Holdings of Steven J Mento

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNAT Conatus Pharmaceuticals Inc 2013-07-30 385,669 0.56 215,975
SGMO Sangamo Therapeutics Inc 2018-04-02 44,046 0.52 22,873

Holding Weightings of Steven J Mento


Steven J Mento Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven J Mento has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the acquisition of 13,800 shares on July 30, 2013, which cost Steven J Mento around $151,800.

According to the SEC Form 4 filings, Steven J Mento has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 7,215 shares on April 2, 2018, which brought Steven J Mento around $132,756.

Insider Trading History of Steven J Mento

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven J Mento Trading Performance

GuruFocus tracks the stock performance after each of Steven J Mento's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven J Mento is -2.19%. GuruFocus also compares Steven J Mento's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven J Mento within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steven J Mento's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steven J Mento

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.66 -2.19 20.77 -9.4 -27.42 -37.26
Relative Return to S&P 500(%) 2.48 -6.78 14.35 -26.25 -39.25 -46.1

Steven J Mento Ownership Network

Ownership Network List of Steven J Mento

No Data

Ownership Network Relation of Steven J Mento


Steven J Mento Owned Company Details

What does Histogen Inc do?

Who are the key executives at Histogen Inc?

Steven J Mento is the director of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .

Histogen Inc (HSTO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Histogen Inc Insider Transactions

No Available Data

Steven J Mento Mailing Address

Above is the net worth, insider trading, and ownership report for Steven J Mento. You might contact Steven J Mento via mailing address: C/o Sangamo Biosciences, Inc., 501 Canal Blvd Suite A-100, Richmond Ca 94804.

Discussions on Steven J Mento

No discussions yet.